BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28145161)

  • 1. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
    Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P; Hu X; Xu X; Chen Y; Bache RJ
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
    Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
    Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
    Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethylarginine dimethylaminohydrolase-1 contributes to exercise-induced cardiac angiogenesis in mice.
    Shi X; Luo X; Xu X
    Biosci Trends; 2020 May; 14(2):115-122. PubMed ID: 32238672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries.
    Ng YYH; Dora KA; Lemmey HAL; Lin J; Alden J; Wallis L; Donovan L; Shorthose O; Leiper FC; Leiper J; Garland CJ
    Hypertension; 2024 Apr; 81(4):764-775. PubMed ID: 38226470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.
    Hou L; Guo J; Xu F; Weng X; Yue W; Ge J
    Basic Res Cardiol; 2018 Jun; 113(4):28. PubMed ID: 29892894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
    Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns.
    He Q; Liu X; Zhong Y; Xu SS; Zhang ZM; Tang LL; Zhang LY; Du LZ
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1285-1295. PubMed ID: 30392707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats.
    Xiao HB; Sui GG; Lu XY; Sun ZL
    Inflammation; 2018 Feb; 41(1):299-306. PubMed ID: 29119338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
    Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP
    J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
    Sun T; Zhou JP; Kuang DB; Li MP; Xiong Y; Tang J; Xia J; Bai YP; Yang GP; Li YJ; Chen XP
    Am J Hypertens; 2013 Dec; 26(12):1437-44. PubMed ID: 23864585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
    Mei X; Zeng J; Liu DF; Zhao Y; Yang HL; Li Y; Qiu P; Tang MW
    Ann Palliat Med; 2021 Mar; 10(3):3343-3353. PubMed ID: 33849119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.